| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/18/2006 | US7078015 Temperature activated gaseous liposomes; therapy drug delivery; accumulating in cancer and disease tissue |
| 07/18/2006 | US7078014 In vivo magnetic resonance imaging by intravenous injection of compounds such as porphyrins, chlorins, bacteriochlorins, and related tetra- pyrrolic compounds with radioactive elements such as Technetium99, Gadolinium, Indium111 and iodine |
| 07/18/2006 | CA2195556C Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 07/13/2006 | WO2006074129A2 Agents for therapy efficacy monitoring and deep tissue imaging |
| 07/13/2006 | WO2006073419A2 Lipoprotein nanoplatforms |
| 07/13/2006 | WO2006073314A1 Optical imaging |
| 07/13/2006 | WO2006072948A2 Gastro-retentive diagnostic assemblies |
| 07/13/2006 | WO2006072580A1 Use of cyanine dyes for the diagnosis of proliferative diseases |
| 07/13/2006 | WO2006072201A1 Particle adjuvant for hifu therapy and the use thereof |
| 07/13/2006 | WO2006072200A1 Adjuvant of fluorocarbon emulsions for hifu therapy and the use thereof |
| 07/13/2006 | WO2006072198A1 A high-intensity focused ultrasound adjuvant and the screening method thereof |
| 07/13/2006 | WO2006072197A1 A high-intensity focused ultrasound plasmid adjuvant and its use |
| 07/13/2006 | WO2006054296A3 Methods of detecting prostate cancer |
| 07/13/2006 | WO2006038185A3 Use of the staudinger ligation in imaging and therapy end kits for imaging and therapy |
| 07/13/2006 | WO2005084710A3 Nanocell drug delivery system |
| 07/13/2006 | WO2005051435A3 Tungsten particles as x-ray contrast agents |
| 07/13/2006 | US20060155190 Imageable biopsy site marker |
| 07/13/2006 | US20060155120 Optically pure and enriched isomers of chelating ligands and contrast agents |
| 07/13/2006 | US20060154989 For use as contrast media; x-ray diagnosis and magnetic resonance imaging |
| 07/13/2006 | US20060153849 Methods of treatment with an antibody that suppresses growth differentiation factor-14 activity |
| 07/13/2006 | US20060153776 Echogen microparticles essentially used as a contrast agent for ultrasound exploration and/or as emboli for ultrasound detection |
| 07/13/2006 | US20060153775 also targeting tumor cells that express vascular endothelial growth factor neuropilin-1 receptor; radiotherapy; radiopharmaceuticals; treating angiogenesis |
| 07/13/2006 | US20060153773 Contrast medium for mri |
| 07/13/2006 | US20060153772 Contextual fear conditioning for predicting immunotherapeutic efficacy |
| 07/13/2006 | US20060153771 Preparations for measuring gastric emptying ability |
| 07/13/2006 | CA2830663A1 Surface enhanced spectroscopy-active composite nanoparticles |
| 07/13/2006 | CA2594390A1 Use of cyanine dyes for the diagnosis of proliferative diseases |
| 07/13/2006 | CA2593638A1 Enhancement agent for high intensity focused ultrasound treatment and method for screening the same |
| 07/13/2006 | CA2593632A1 Plasmid enhancement agent for high intensity focused ultrasound treatment and use thereof |
| 07/13/2006 | CA2593256A1 Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications |
| 07/13/2006 | CA2587172A1 Radiation dosimetry and blocking antibodies and methods and uses threfor in the treatment of cancer |
| 07/12/2006 | EP1679084A1 X-ray contrast medium containing liposome and method for preparation thereof |
| 07/12/2006 | EP1679083A2 Use of metaloporphyrins for treatment of arteriosclerotic lesions |
| 07/12/2006 | EP1679082A1 Use of cyanine dyes for the diagnosis of proliferative diseases |
| 07/12/2006 | EP1679077A1 Mucous membrane bulging humor composition comprising chitosan derivative containing saccharide chain for use in condoscopic surgery |
| 07/12/2006 | EP1678328A2 Ntrk1 genetic markers associated with age of onset of alzheimer's disease |
| 07/12/2006 | EP1677677A1 Contrast media for use in medical and diagnostic procedures and methods of using the same |
| 07/12/2006 | EP1677669A1 Semipermeable sensors for detecting analyte |
| 07/12/2006 | EP1499292A4 In vivo imaging of apoptosis |
| 07/12/2006 | EP0977594B1 Ultrasound imaging of tissue perfusion by pulse energy disruption of contrast agent |
| 07/12/2006 | CN1800150A Iodine Ioxilan purification method |
| 07/12/2006 | CN1800149A Iodine Ioxilan preparation method |
| 07/12/2006 | CN1799631A Animal model for fetal alcohol syndrome and methods of treatment |
| 07/12/2006 | CN1263516C Medicine preparations for diagnosing helicobacter pyloni infection |
| 07/12/2006 | CN1263515C Blood pool agents for nuclear magnetic resonance diagnosis |
| 07/12/2006 | CN1263514C Fluoro labeled anthracyclinone and anthracycline derivatives |
| 07/11/2006 | US7074613 Monoclonal antibody directed against cells of human renal cell carcinoma |
| 07/11/2006 | US7074574 Method of detecting growth differentiation factor-7 (GDF-7) using GDF-7 antibodies |
| 07/11/2006 | US7074405 antibody binds target tissue and conjugate carrying epitope (haptens) |
| 07/11/2006 | US7074387 DTPA monoamides, pharmaceutical agents containing these compounds, their use and process for their production |
| 07/06/2006 | WO2006071891A2 Evaluating central nervous system |
| 07/06/2006 | WO2006069676A1 Hydroxypyridinone derivatives, their metal complexes and their use in the production of conjugates with biomolecules |
| 07/06/2006 | WO2006044856A3 Use of a2a adenosine receptor agonists |
| 07/06/2006 | WO2005121787A3 Lat1 transporters expressed in cancer cells |
| 07/06/2006 | WO2005087367A8 Magnetic composite particle and process for producing the same |
| 07/06/2006 | US20060150259 Model of bone disease amenable to high-throughput screening |
| 07/06/2006 | US20060149159 Method for measuring pancreatic metabolism |
| 07/06/2006 | US20060148761 Lipids |
| 07/06/2006 | US20060148739 Method of evaluating compound efficacious in treating obesity |
| 07/06/2006 | US20060148683 Detection and treatment of intravascular lesions |
| 07/06/2006 | US20060148682 Identifying substrate of an enzyme that is secreted by MCF7/6, HepG2, or HT29 cells; covalently attaching by amidation or esterification the substrate to drug to form a prospective tumor-activated prodrug; drug screening and testing; antitumor, antiinflammatory and anticarcinogenic agents; diagnosis |
| 07/06/2006 | US20060148001 Compositions and methods for treating female fertility |
| 07/06/2006 | US20060147496 Diagnosis of irritable bowel disorders; fibromyalgia; chronic fatique syndrome; antidepressants; tinnitus; autism; autoimmune disease; Crohn's disease; quantitative analysis of serotonine, bile acid in sample |
| 07/06/2006 | US20060147444 Biosynthetic binding proteins for immuno-targeting |
| 07/06/2006 | US20060147427 Method for immunotherapy of tumors |
| 07/06/2006 | US20060147381 Microparticles for selectively targeted hyperthermia |
| 07/06/2006 | US20060147380 Integrin targeted imaging agents |
| 07/06/2006 | US20060147379 Targeted, NIR imaging agents for therapy efficacy monitoring, deep tissue disease demarcation and deep tissue imaging |
| 07/06/2006 | US20060147378 Azulene dimer-quenched, near-infrared fluorescent probes |
| 07/06/2006 | US20060147377 tumor cell line, reponsive to histone deacetylase inhibitors, transfected with vector containing reporter gene such as fluorescent protein, linked to promotor that also controls expression of protein associated with tumor regression, stabilization of tumor growth or inhibition of metastatic growth |
| 07/06/2006 | US20060147376 Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier |
| 07/06/2006 | US20060147371 Sustained delivery of chemotherapeutic agent at high concentration without damaging normal cells beyond repair |
| 07/06/2006 | US20060146644 System for producing micro-cluster liquids |
| 07/06/2006 | DE102004063339A1 Sonde zum Nachweis von Nukleinsäuren Probe for detecting nucleic acids |
| 07/06/2006 | DE102004062250A1 Konjugate von Hydroxypyridinonderivat-Metallkomplexen mit Biomolekülen und deren Verwendung zur Herstellung von Mitteln für die NMR-Diagnostik Conjugates of Hydroxypyridinonderivat-metal complexes with biomolecules and their use for the production of agents for NMR diagnosis |
| 07/06/2006 | DE102004061348A1 Verfahren zur Auswahl eines geeigneten Kontrastmittels für die Durchführung einer bildgebenden Untersuchung bei einem Patienten und Verwendungen des im ausgewählten Kontrastmittel enthaltenen Liganden A process for the selection of a suitable contrast medium for carrying out an imaging examination for a patient and uses of the ligands contained in the selected contrast agent |
| 07/05/2006 | EP1676833A1 Propionic acid derivatives useful in the treatment of lipid disorders |
| 07/05/2006 | EP1675820A2 Propionic acid derivatives useful in the treatment of lipid disorders |
| 07/05/2006 | EP1675624A1 Stationary target mr imaging |
| 07/05/2006 | EP1573044A4 Serum biomarkers in lung cancer |
| 07/05/2006 | EP1435774A4 Enhanced resolution of tumor metastasis |
| 07/05/2006 | EP1280404B1 Model for neurodegenerative disease |
| 07/05/2006 | EP1107979B1 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 07/05/2006 | EP1096955B9 Uses of antibodies to aminophospholipids for cancer treatment |
| 07/05/2006 | CN1798839A Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases |
| 07/05/2006 | CN1798569A Therapeutic vaccine compositions for the treatment of type 1 diabetes |
| 07/05/2006 | CN1798545A Method for improving stability and shelf-life of liposome complexes |
| 07/05/2006 | CN1796411A New protein DDIP and coding genes and application |
| 07/05/2006 | CN1795929A Method for generating model of chmice in male sterile |
| 07/04/2006 | US7071168 To inhibit tumor growth in an animal; to induce apoptosis |
| 07/04/2006 | US7070939 Methods for detecting vasculopathies and tumors |
| 07/04/2006 | US7070810 Use of buckysome or carbon nanotube for drug delivery |
| 07/04/2006 | US7070809 Hydrogel biomedical articles |
| 07/04/2006 | US7070793 Antigen protein and nucleic acid coding for said protein |
| 07/04/2006 | US7070760 injecting platelet derived proteins having a pI of 6.5-9.5 and detecting the occurrence of delayed type hypersensitivity (DTH) reaction at the injection site; positive reacting indicates high likelihood of being schizophrenic |
| 07/04/2006 | US7070565 Solid hydrogel coupling for ultrasound imaging and therapy |
| 07/04/2006 | CA2319544C Bibapcitide-based pharmaceutical compositions for imaging and treating thrombi |
| 06/29/2006 | WO2006068639A1 Oral contrast media composition for computerized axial tomographic examinations and method |
| 06/29/2006 | WO2006068294A1 Contrast medium |
| 06/29/2006 | WO2006051153A3 Methods and devices for facile fabrication of nanoparticles and their applications |